Mark Turner, Women's and Children's Health, University of Liverpool, UK
BSc; MBChB, PhD, CCST in Paediatrics / Neonatal medicine (Clinical training, Liverpool / Manchester)
Mark Turner is a Senior Lecturer in Neonatology at the University of Liverpool and Honorary Consultant Neonatologist to Liverpool Women’s NHS Foundation Trust. He trained in paediatrics in the North West of England and neonatal medicine in Liverpool and Manchester before starting as a Consultant at LWH in 2005.
His particular clinical interest is babies who are born very early including pain relief and communication with families. With a passion for improving the medicines that are given to babies and children, he has studied more than 15 medicines given to premature babies and examined methods to evaluate drug safety, medicines administration and the costs of off-label medicines.
This experience has led him to work with regulators, pharmaceutical and research networks in the UK, Europe and globally to improve the way that research involving children is carried out.
He represents LWH on the Executive and Board of the National Co-ordinating Centre of the U.K. Medicines for Children Research Network (MCRN) and the Advisory Board of the Cheshire, Merseyside and North Wales Medicines for Children Local Research Network. He is a member of the MCRN Clinical Studies Groups in Neonatal Medicine, General Paediatrics and Anaesthesia, Pain, Paediatric Intensive Care and Cardiology.